Prolonged use of highly active antiretroviral therapy to treat people infected with both HIV and hepatitis B helps to better control the hepatitis B infection and could delay or prevent liver complications, according to a new study.
Prolonged use of highly active antiretroviral therapy to treat people infected with both HIV and hepatitis B helps to better control the hepatitis B infection and could delay or prevent liver complications, according to a new study.